Ono Pharmaceutical co., ltd.

Dec 05, 2024

Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area

Jun 11, 2024

Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono)

Apr 30, 2024

ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals

Mar 25, 2024

ONO PHARMA Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL

Mar 11, 2024

ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University

Feb 20, 2024

Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets

Feb 14, 2024

Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins